Sage Therapeutics Inc. buy melinda
Start price
11.11.18
/
50%
€117.61
Target price
22.01.19
€153.34
Performance (%)
3.72%
End price
22.01.19
€121.99
Summary
This prediction ended on 22.01.19 with a price of €121.99. The BUY prediction by melinda finished with a performance of 3.72%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to melinda what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Sage Therapeutics Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 14/11 | 15:30 Présentation
Oppenheimer a fixé un objectif de prix de 170,00 $ sur SAGE Therapeutics (NASDAQ: SAGE) une cible de recherche publiée dimanche. La société a actuellement une cote d'agat sur les actions de la société biopharmaceutique.
(Vom Mitglied beendet)
Stopped prediction by melinda for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.92
19.06.21
19.06.21
€58.00
19.06.22
19.06.22
-20.72%
27.12.21
27.12.21
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.56
19.09.17
19.09.17
€78.47
09.11.17
09.11.17
46.88%
09.11.17
09.11.17
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€62.71
19.09.17
19.09.17
€87.00
09.11.17
09.11.17
46.88%
09.11.17
09.11.17
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.96
12.07.16
12.07.16
€44.20
10.11.16
10.11.16
7.26%
10.11.16
10.11.16
Could be worthwhile Investment >10% per year